Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients (CotoCFII)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03341741 |
|
Recruitment Status :
Completed
First Posted : November 14, 2017
Last Update Posted : November 14, 2017
|
Sponsor:
University Hospital Tuebingen
Information provided by (Responsible Party):
University Hospital Tuebingen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 19, 2015 |
| Actual Study Completion Date : | November 25, 2016 |